We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant

Delisted

PAVMZ was delisted on the 30th of April, 2025.

6 hedge funds and large institutions have $533K invested in PAVmed Inc. Series Z Warrant in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% more funds holding

Funds holding: 66 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

28% less capital invested

Capital invested by funds: $737K → $533K (-$204K)

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
LCS
1
Levin Capital Strategies
New York
$424K +$9.04K +10,000 +3%
ICM
2
Ionic Capital Management
New York
$90K
WAM
3
Wolverine Asset Management
Illinois
$15K -$1.05K -1,158 -8%
TWA
4
TCI Wealth Advisors
Arizona
$2K +$452 +500 +63%
Bank of America
5
Bank of America
North Carolina
$1K
Morgan Stanley
6
Morgan Stanley
New York
$1K +$452 +500 New
SM
7
Sabby Management
Florida
-$364K -436,973 Closed

PAVMZ Hedge Fund Activity: Q4 2020 in Review

6 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q4 2020, worth a combined $533K — down 28% from $737K a quarter earlier.

Fund positioning in PAVMZ was balanced in Q4 2020: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $9.04K. The largest seller was Sabby Management, exiting entirely with an estimated $364K sold.

  • 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $533K of PAVmed Inc. Series Z Warrant stock for Q4 2020, down 28% quarter-over-quarter.
  • 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q4 2020 and 1 closed out, a net change of 0 holders.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q4 2020 was Levin Capital Strategies, an estimated $9.04K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q4 2020 was Sabby Management, an estimated $364K sold.

Based on aggregated 13F filings for Q4 2020.